{"id":4245,"date":"2026-10-12T08:32:23","date_gmt":"2026-10-12T08:32:23","guid":{"rendered":"https:\/\/nhdbio.com\/?p=4245"},"modified":"2026-10-12T08:32:23","modified_gmt":"2026-10-12T08:32:23","slug":"semaglutid-dosissteigerung-leberfett-mrt-erklart","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/semaglutide-step-up-liver-fat-mri-explained\/","title":{"rendered":"Semaglutid und Leberfett: den R\u00fcckgang von 8.8% auf 3.1% verstehen"},"content":{"rendered":"<div class=\"nhd-news-lesson\">\n<figure class=\"cover\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp\" alt=\"Thematic illustration of a researcher checking a liver model alongside MRI information\" width=\"1672\" height=\"941\"><figcaption>Editorial illustration, not an experimental photograph.<\/figcaption><\/figure>\n<p class=\"lead\">After weight loss, does the fat in the liver also decrease? An analysis announced on October 1 used MRI scans to answer this question. The results are worth attention, but first we need to be clear: who was scanned, and what the numbers actually represent.<\/p>\n<section class=\"section\" id=\"section-1\">\n<h2>Fat in the liver is different from fat around the waist<\/h2>\n<p>Fat is not only stored under the skin; it can also build up in the liver. Whether someone looks heavy or not does not directly tell us how much liver fat they have; and how much weight they lose cannot directly replace a liver examination.<\/p>\n<p>This study used MRI to estimate the proportion of liver fat. What it provides is information about liver fat content, not the results of taking liver tissue samples and looking at inflammation or scarring.<\/p>\n<\/section>\n<section class=\"section\" id=\"section-2\">\n<h2>55 people had MRI scans, and 26 people initially had more than 5%<\/h2>\n<p>This post-hoc analysis came from some participants in the STEP UP trial, a total of 55 adults with obesity but without diabetes. The study combined data from two doses of semaglutide and followed participants through week 72.<a class=\"source-ref\" href=\"#sources\" aria-label=\"View the original source\">[1]<\/a><\/p>\n<p>Among them, 26 people started with liver fat above 5%. By week 72, 23 people had values that dropped below 5%. Therefore, the news phrase &quot;nearly ninety percent returned to the normal range&quot; refers to 23 divided by 26, not ninety percent out of 55 people, and not that every patient with fatty liver disease would respond this way.<\/p>\n<\/section>\n<section class=\"section\" id=\"section-3\">\n<h2>From 8.8% to 3.1%, how much was actually reduced?<\/h2>\n<p>In the combined treatment group, the average liver fat proportion fell from 8.8% to 3.1%. Subtracting the two numbers gives 5.7 percentage points; then dividing 5.7 by 8.8 gives a relative reduction of about 64.8%.<a class=\"source-ref\" href=\"#sources\" aria-label=\"View the original source\">[1]<\/a><\/p>\n<p>Both calculations can describe the same change, but they mean different things. It is like a temperature dropping from 30 degrees to 20 degrees: first you say it fell by 10 degrees; when talking about proportion, you then explain how large that 10 is relative to the starting point. Here, too, &quot;reduced by about 65%&quot; cannot be understood as losing 65% of total body fat.<\/p>\n<aside class=\"helper\" aria-label=\"Read the supporting illustration\">\n<div class=\"helper-title\">Keep the two calculation methods separate<\/div>\n<div class=\"steps\">\n<div class=\"step\"><strong>8.8% \u2192 3.1%<\/strong><small>Average liver fat proportion in the same group<\/small><\/div>\n<p><span class=\"arrow\" aria-hidden=\"true\">\u2192<\/span><\/p>\n<div class=\"step\"><strong>Reduced by 5.7 percentage points<\/strong><small>Subtract the two numbers<\/small><\/div>\n<p><span class=\"arrow\" aria-hidden=\"true\">\u2192<\/span><\/p>\n<div class=\"step\"><strong>Relative reduction of about 64.8%<\/strong><small>5.7 \u00f7 8.8 \u00d7 100%<\/small><\/div>\n<\/div>\n<p class=\"helper-note\">This is an explanatory calculation based on the announced values, not the proportion of total body fat reduced.<\/p>\n<\/aside>\n<\/section>\n<section class=\"section\" id=\"section-4\">\n<h2>Why can&#039;t we directly say fatty liver disease has been cured?<\/h2>\n<p>A reduction in fat is a valuable change, but liver inflammation, fibrosis, and long-term complications each still require their own examinations or follow-up. This analysis was also an additional question asked after the trial was completed, involved fewer people, and combined doses.<\/p>\n<p>The announcement also described a larger combined population analysis, involving 1919 people and a liver risk score. The score data and the MRI results from 55 people come from different analyses, and cannot be pieced together to say that &quot;all 1919 people had MRI scans.&quot;<\/p>\n<\/section>\n<section class=\"section\" id=\"section-5\">\n<h2>What should researchers look at next?<\/h2>\n<p>More convincing follow-up studies should define liver changes as an observation goal in advance, specify the control group, dose, and starting disease severity, and track inflammation or fibrosis. Only then is it easier to judge how stable the fat changes are and which people benefit more.<\/p>\n<p>For readers, the most useful reminder from this news is: when evaluating weight-loss research, besides the scale, you can also look at what happens to fat inside the body.<\/p>\n<\/section>\n<section class=\"section\" id=\"section-6\">\n<h2>If liver fat is below 5%, does that mean it will never rise again?<\/h2>\n<p>A single examination falling into a lower range only shows the state at that measurement. Whether it stays there afterward also depends on later weight, metabolism, and treatment. To answer whether it rebounds, continuous follow-up is needed.<\/p>\n<p>When you receive a similar report, it is best to keep the examination date, the method used, and your weight at that time together. Comparing the same method over time is usually easier to understand than putting single results from different methods side by side.<\/p>\n<\/section>\n<aside class=\"takeaway\"><strong>When reading this, remember this point<\/strong><\/p>\n<p>23\/26 is the result of a specific subgroup; a drop in liver fat and proof of improvement in inflammation or fibrosis are different questions.<\/p>\n<\/aside>\n<section class=\"materials\" id=\"materials\">\n<div class=\"eyebrow\">Related research materials<\/div>\n<h2>View materials and analysis information<\/h2>\n<p class=\"materials-intro\">For experiments related to GLP-1, you can view custom peptide services and check the required sequence, modifications, and analytical requirements. The current catalog does not have a separate semaglutide page, and this article does not provide links to products that do not exist.<\/p>\n<div class=\"product-grid\">\n<article class=\"product-card\">\n<div class=\"card-head\">\n<div>\n<div class=\"product-label\">Sequence, modification, and analysis requirements<\/div>\n<h3>Custom peptide services<\/h3>\n<\/div>\n<\/div>\n<div class=\"card-body\">\n<p>Describe the required sequence, terminal form, quantity, and testing requirements, and confirm the delivery scope according to the project.<\/p>\n<p><a href=\"https:\/\/nhdbio.com\/services\/custom-peptide-synthesis\/\" target=\"_blank\" rel=\"noopener\">Learn about custom services \u2192<\/a><\/div>\n<\/article>\n<\/div>\n<\/section>\n<section class=\"sources\" id=\"sources\">\n<h2>Original materials<\/h2>\n<div>Material date: 2026-10-01 \u00b7 Post-hoc exploratory analysis of a human trial<\/div>\n<ul>\n<li><a href=\"https:\/\/www.novonordisk.com\/news-and-media\/news-and-ir-materials\/news-details.html?id=917205\" target=\"_blank\" rel=\"noopener\">Original announcement\/research release page \u2197<\/a><\/li>\n<\/ul>\n<\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nach Gewichtsverlust: Nimmt auch das Fett in der Leber ab? Eine am 1 Oktober angek\u00fcndigte Analyse nutzte MRT-Scans, um diese Frage zu beantworten. Die Ergebnisse sind beachtenswert, aber zuerst m\u00fcssen wir klarstellen: Wer wurde gescannt, und was die Zahlen tats\u00e4chlich darstellen.<\/p>","protected":false},"author":1,"featured_media":4244,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"","pim_article_type":"Published research explained","pim_evidence_level":"Post-hoc exploratory analysis of a human trial","pim_reviewer":"AI-assisted source and editorial check","pim_reviewed_date":"2026-10-12","pim_editorial_note":"Original public sources, study populations and limitations are linked. Editorial illustrations are not experimental photographs.","pim_review_status":"reviewed","pim_review_reason":"Reviewed Chinese source, protected scientific values and links, unique illustration, related product families and responsive layout checked.","pim_creation_method":"AI-assisted writing","pim_sources":"[{\"title\":\"Research news reference \u2014 www.novonordisk.com \u2014 news-01\",\"note\":\"\",\"url\":\"https:\/\/www.novonordisk.com\/news-and-media\/news-and-ir-materials\/news-details.html?id=917205\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-4245","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Semaglutide and liver fat: understanding the drop from 8.8% to 3.1% | NHD<\/title>\n<meta name=\"description\" content=\"After weight loss, does the fat in the liver also decrease? An analysis announced on October 1 used MRI scans to answer this question. The results are worth attention, but first we need to be clear: who was scanned, and what the numbers actually represent.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/semaglutid-dosissteigerung-leberfett-mrt-erklart\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1%\" \/>\n<meta property=\"og:description\" content=\"After weight loss, does the fat in the liver also decrease? An analysis announced on October 1 used MRI scans to answer this question. The results are worth attention, but first we need to be clear: who was scanned, and what the numbers actually represent.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/semaglutid-dosissteigerung-leberfett-mrt-erklart\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-12T08:32:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1%\",\"datePublished\":\"2026-10-12T08:32:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/\"},\"wordCount\":791,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-news-20261012-01.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/\",\"name\":\"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1% | NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-news-20261012-01.webp\",\"datePublished\":\"2026-10-12T08:32:23+00:00\",\"description\":\"After weight loss, does the fat in the liver also decrease? An analysis announced on October 1 used MRI scans to answer this question. The results are worth attention, but first we need to be clear: who was scanned, and what the numbers actually represent.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-news-20261012-01.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-news-20261012-01.webp\",\"width\":1672,\"height\":941,\"caption\":\"Thematic illustration of a researcher checking a liver model alongside MRI information\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/semaglutide-step-up-liver-fat-mri-explained\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Semaglutid und Leberfett: den R\u00fcckgang von 8.8% auf 3.1% verstehen | NHD","description":"Nach Gewichtsverlust: Nimmt auch das Fett in der Leber ab? Eine am 1 Oktober angek\u00fcndigte Analyse nutzte MRT-Scans, um diese Frage zu beantworten. Die Ergebnisse sind beachtenswert, aber zuerst m\u00fcssen wir klarstellen: Wer wurde gescannt, und was die Zahlen tats\u00e4chlich darstellen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/semaglutid-dosissteigerung-leberfett-mrt-erklart\/","og_locale":"de_DE","og_type":"article","og_title":"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1%","og_description":"After weight loss, does the fat in the liver also decrease? An analysis announced on October 1 used MRI scans to answer this question. The results are worth attention, but first we need to be clear: who was scanned, and what the numbers actually represent.","og_url":"https:\/\/nhdbio.com\/de\/semaglutid-dosissteigerung-leberfett-mrt-erklart\/","og_site_name":"NHD","article_published_time":"2026-10-12T08:32:23+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1%","datePublished":"2026-10-12T08:32:23+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/"},"wordCount":791,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp","articleSection":["Published Study Reviews"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/","url":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/","name":"Semaglutid und Leberfett: den R\u00fcckgang von 8.8% auf 3.1% verstehen | NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp","datePublished":"2026-10-12T08:32:23+00:00","description":"Nach Gewichtsverlust: Nimmt auch das Fett in der Leber ab? Eine am 1 Oktober angek\u00fcndigte Analyse nutzte MRT-Scans, um diese Frage zu beantworten. Die Ergebnisse sind beachtenswert, aber zuerst m\u00fcssen wir klarstellen: Wer wurde gescannt, und was die Zahlen tats\u00e4chlich darstellen.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-news-20261012-01.webp","width":1672,"height":941,"caption":"Thematic illustration of a researcher checking a liver model alongside MRI information"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/semaglutide-step-up-liver-fat-mri-explained\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Semaglutide and liver fat: understanding the drop from 8.8% to 3.1%"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/4245","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=4245"}],"version-history":[{"count":3,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/4245\/revisions"}],"predecessor-version":[{"id":4248,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/4245\/revisions\/4248"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/4244"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=4245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=4245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=4245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}